Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$14,493,913
+$5,779,093 QoQ
Shares Held
12,084
+27.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.75%
of 13F equity value
Holder Rank
#1,051
of 4,605 holders
Holding Since
Dec 2021
17 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PALISADE CAPITAL MANAGEMENT, LP holds $44,577,032 across 7 Drug Manufacturers - General names. LLY ranks #2 (32.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
70,905 | $17,842,534 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
12,084 | $14,493,913 | |
| 3 | JNJ |
Johnson & Johnson
|
23,321 | $5,922,834 | |
| 4 | NVO |
Novo Nordisk A S
|
113,575 | $5,444,785 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
2,742 | $346,424 | |
| 6 | AZN |
Astrazeneca PLC
|
1,412 | $267,743 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,014 | $258,799 |
All Filings in LLY
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,493,913 | 12,084 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $8,714,820 | 9,475 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,316,483 | 1,225 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $510,447 | 669 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $304,796 | 391 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $264,291 | 320 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $247,040 | 320 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $283,500 | 320 | Shares | Sole | 2024-11-14 | |
| 2023-12-31 | $434,275 | 745 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $400,161 | 745 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $349,390 | 745 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $255,847 | 745 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $272,550 | 745 | Shares | Sole | 2023-03-24 | |
| 2022-09-30 | $240,895 | 745 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $241,551 | 745 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $213,345 | 745 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $276,220 | 1,000 | Shares | Sole | 2022-04-21 | |
| No filing history on record for this holder in this stock. | ||||||